MetLife Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$647K	Buy	184,399 +13,617	+8%	+$43.6K	﹤0.01%	1628
2025 Q4	$466K	Buy	170,782 +29,096	+21%	+$67.3K	﹤0.01%	1821
2025 Q3	$307K	Sell	141,686 -9,288	-6%	-$21.9K	﹤0.01%	2069
2025 Q2	$260K	Sell	150,974 -232	-0.2%	-$577	﹤0.01%	2041
2025 Q1	$504K	Sell	151,206 -14,636	-9%	-$75.5K	﹤0.01%	1726
2024 Q4	$1.23M	Buy	165,842 +19,426	+13%	+$180K	0.01%	1312
2024 Q3	$1.37M	Hold	146,416	–	–	0.01%	1210
2024 Q2	$1.17M	Buy	146,416 +25,310	+21%	+$271K	0.01%	1260
2024 Q1	$1.79M	Hold	121,106	–	–	0.01%	1000
2023 Q4	$985K	Hold	121,106	–	–	0.01%	1301
2023 Q3	$551K	Buy	121,106 +11,390	+10%	+$74.4K	﹤0.01%	1574
2023 Q2	$772K	Buy	109,716 +31,145	+40%	+$223K	0.01%	1420
2023 Q1	$480K	Hold	78,571	–	–	﹤0.01%	1673
2022 Q4	$502K	Hold	78,571	–	–	﹤0.01%	1644
2022 Q3	$753K	Hold	78,571	–	–	0.01%	1344
2022 Q2	$867K	Buy	78,571 +73,566	+1,470%	+$964K	0.01%	1286
2022 Q1	$83.3K	Buy	+5,005	New	+$77.4K	﹤0.01%	2645
2020 Q2	–	Sell	-49,133	Closed	-$1.47M	–	2326
2020 Q1	$1.47M	Sell	49,133 -2,460	-5%	-$65.2K	0.02%	738
2019 Q4	$1.43M	Hold	51,593	–	–	0.01%	939
2019 Q3	$939K	Buy	51,593 +3,281	+7%	+$72.6K	0.01%	1102
2019 Q2	$1.18M	Hold	48,312	–	–	0.01%	1029
2019 Q1	$459K	Hold	48,312	–	–	0.01%	1504
2018 Q4	$428K	Buy	48,312 +9,549	+25%	+$92.1K	0.01%	1461
2018 Q3	$436K	Buy	+38,763	New	+$550K	﹤0.01%	1616